Stefanos Theoharis

Chief Executive Officer · OneChain Immunotherapeutics · company speakers →

Stefanos Theoharis brings over 20 years of broad experience in the cell and gene therapy space, business development, program management, manufacturing and basic research brings a deep knowledge CGT sector. Former CBO of Bone Therapeutics, Belgium-based company, developing specialized cell therapies for orthopaedic disorders. Prior to that he was Senior Vice-President at Cell Medica, and CBO at apceth GmbH. He also held positions, among others, as Director Business Development at Roche, focused on partnering activities in emerging science and technologies and M&A Analyst at Lazard, the global investment bank. He holds a PhD in gene therapy and immunology from Imperial College London.

pharma-biotechhealthcare-services

Is this you? Claim this profile →

No public contact links on file.

Speaking history

In Vivo Cell Engineering & Gene Editing Summit

28 July 2026 Boston, United States “A Novel Differentiated In Vivo Lentiviral Platform”

Advanced Therapies Europe

7 September 2026 Barcelona, Spain

Advanced Therapies Week

18 January 2027 San Diego, United States

Topics this speaker covers

pharma-biotechhealthcare-services

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →